Viewing StudyNCT00451958



Ignite Creation Date: 2024-05-05 @ 5:26 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00451958
Status: COMPLETED
Last Update Posted: 2013-03-21
First Post: 2007-03-23

Brief Title: A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy
Sponsor: Ferring Pharmaceuticals
Organization: Ferring Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
Degarelix View
prostate cancer View